Search Results 561-570 of 13993 for anti-TNF drugs

  1. Pentostatin (intravenous route) - Mayo Clinic

    Pentostatin belongs to the group of medicines called antimetabolites. It is used to treat a type of cancer of the white blood cells called hairy cell leukemia.

  2. A Study to Evaluate TAK-018 for Prevention of the Recurrence of Postoperative Crohn's Disease (CD) - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search tips ... This includes anti-tumor necrosis factor-alpha (TNF ...

  3. Untitled

    Page 1. Page 2.

  4. Namilumab in Subjects with Chronic Pulmonary Sarcoidosis - Mayo Clinic

    Drugs & Supplements A-Z · Health Books · Healthy Living Program · Mayo Clinic ... Use of biologic — approved or investigational agents (e.g., anti-TNFα, anti ...

  5. Cholesterol-lowering supplements may be helpful - Mayo Clinic

    With your doctor's OK, here are some cholesterol-improving supplements to consider. Cholesterol-improving supplement, What it might do, Side effects and drug ...

  6. A Study to Test the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer - Mayo Clinic

    This study aims to assess if adding immunotherapy to these drugs is better or worse than the usual approach for treatment of this cancer. Participation ...

  7. A Study to Evaluate Estrogen Receptor (ER) Reactivation Therapy for Breast Cancer - Mayo Clinic

    ... treatment with either type of therapy in patients with metastatic anti-estrogen-resistant ER+ breast cancer. Participation eligibility. Participant ...

  8. CD19-Directed CAR-T Cell Therapy for the Treatment of Relapsed/​Refractory B Cell Malignancies - Mayo Clinic

    The therapy, IC19/1563, uses some of the patients own immune cells, called T cells, to kill cancer. T cells fight infections and, in some cases, can also kill ...

  9. New treatment option for early type 1 diabetes - Mayo Clinic

    According to findings published in The New England Journal of Medicine in 2023, teplizumab is an anti-CD3 antibody approved for people 8 years and older ...

  10. Dofetilide (oral route) - Mayo Clinic

    Weigh the potential benefits against the potential risks before taking this medication while breastfeeding. Drug Interactions. Although certain medicines should ...